- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2015-001487-19.
Displaying page 1 of 1.
| EudraCT Number: 2015-001487-19 | Sponsor Protocol Number: 35/14 | Start Date*: 2016-04-07 |
| Sponsor Name:Swiss Group For Clinical Cancer Research (SAKK) | ||
| Full Title: Rituximab with or without Ibrutinib for untreated patients with advanced follicular lymphoma in need of therapy. | ||
| Medical condition: Follicular Lymphoma (FL), advanced disease in need of therapy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Completed) DK (Prematurely Ended) SE (Ongoing) FI (Completed) AT (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.